Anbok Lee Selected Research

Anbok Lee Research Topics

Disease

21	Breast Neoplasms (Breast Cancer) 04/2022 - 12/2011
15	Neoplasms (Cancer) 04/2022 - 12/2011
1	Adenocarcinoma of Lung 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 09/2019
1	Triple Negative Breast Neoplasms 10/2018
1	Paraproteinemias (Monoclonal Gammopathy) 03/2018
1	Rectal Neoplasms (Rectal Cancer) 12/2017
1	Calcinosis 12/2016
1	Carcinogenesis 06/2016
1	Neoplasm Metastasis (Metastasis) 06/2016
1	Brain Neoplasms (Brain Tumor) 06/2016
1	Dermatitis 01/2014
1	Colitis 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2014
1	Critical Illness (Critically Ill) 07/2012
1	Stomach Neoplasms (Stomach Cancer) 06/2011

Drug/Important Bio-Agent (IBA)

3	taxaneIBA 08/2019 - 12/2011
3	Hormones (Hormone)IBA 01/2019 - 03/2014
2	ErbB Receptors (EGF Receptor)IBA 04/2022 - 01/2018
2	Glutathione (Reduced Glutathione)IBA 08/2021 - 08/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 09/2019 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 09/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 09/2019 - 01/2019
2	AnthracyclinesIBA 10/2018 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 03/2018 - 06/2016
2	EnzymesIBA 01/2018 - 06/2016
2	human ERBB2 proteinIBA 06/2016 - 03/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 01/2014
2	Glutathione Peroxidase GPX1IBA 01/2014 - 01/2014
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2014 - 01/2014
1	Monoclonal AntibodiesIBA 04/2022
1	navitoclaxIBA 01/2022
1	AcriflavineIBA 01/2022
1	purineIBA 08/2021
1	Glutamine (L-Glutamine)FDA Link 08/2021
1	Amino Acids FDA Link 08/2021
1	CarbonIBA 08/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2020
1	Adenosine Diphosphate (ADP)IBA 03/2020
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 03/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2020
1	Annexin A5IBA 01/2020
1	lissamine rhodamine B (sulforhodamine B)IBA 01/2020
1	LigandsIBA 09/2019
1	Neuregulin-1 (Neuregulin 1)IBA 09/2019
1	TransferasesIBA 08/2019
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 08/2019
1	Docetaxel (Taxotere)FDA Link 08/2019
1	octanoylcarnitineIBA 01/2019
1	Aldehyde Dehydrogenase 1 FamilyIBA 05/2018
1	Sepharose (Agarose)IBA 03/2018
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	malachite greenIBA 01/2017
1	Sodium AzideIBA 01/2017
1	aniline (aniline hydrobromide)IBA 01/2017
1	Y-Box-Binding Protein 1IBA 09/2016
1	eribulin FDA Link 06/2016
1	Phenobarbital (Luminal)FDA Link 06/2016
1	Nucleic AcidsIBA 06/2016
1	LectinsIBA 06/2016
1	Fluconazole (Zonal)FDA LinkGeneric 03/2014
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2014
1	Glutathione PeroxidaseIBA 01/2014
1	CatalaseIBA 01/2014
1	Imiquimod (Aldara)FDA LinkGeneric 01/2014
1	2,3-dimethoxy-1,4-naphthoquinoneIBA 01/2014
1	neutrophil cytosolic factor 1IBA 01/2014
1	Dextrans (Dextran)FDA Link 01/2014
1	PeroxiredoxinsIBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 06/2013
1	Adenosine Triphosphate (ATP)IBA 06/2013
1	Cystatin CIBA 07/2012
1	Polyglactin 910IBA 07/2012
1	CreatinineIBA 07/2012

Therapy/Procedure

5	Neoadjuvant Therapy 09/2019 - 12/2016
4	Therapeutics 04/2022 - 06/2013
4	Drug Therapy (Chemotherapy) 03/2020 - 12/2011
3	Radiotherapy 02/2022 - 03/2020
1	Immunotherapy 01/2020
1	Hyperbaric Oxygenation 01/2014
1	Segmental Mastectomy (Lumpectomy) 07/2012
1	Adjuvant Chemotherapy 12/2011
1	Lymph Node Excision (Lymph Node Dissection) 06/2011